Celldex Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.1M | 99k | 41.97 |
| 2023-12-31 | $3.0M | 76k | 39.66 |
| 2023-09-30 | $2.1M | 77k | 27.52 |
| 2023-06-30 | $2.5M | 74k | 33.93 |
| 2023-03-31 | $2.7M | 74k | 35.98 |
| 2022-12-31 | $3.2M | 72k | 44.57 |
| 2022-09-30 | $2.0M | 70k | 28.11 |
| 2022-06-30 | $1.8M | 65k | 26.96 |
| 2022-03-31 | $1.8M | 52k | 34.07 |
| 2021-12-31 | $1.9M | 50k | 38.64 |
| 2021-09-30 | $2.7M | 49k | 53.99 |
| 2021-06-30 | $1.4M | 41k | 33.45 |